Group items tagged

The UK based Pharma giant Futura Medical Plc's lead product, Eroxon, a topical Stim-gel is now available on NHS prescription in England and Wales for the treatment of Erectile Dysfunction (ED). The Muti-Drug Resistant (MDR) approved alternative to PDE5i, Eroxon is available as an over-the counter off shelf at retailers like Boots and Superdrug; and is available on NHS prescription in England and Wales as a CE-marked medical device. Erectile dysfunction (ED), also known as impotence, is the inability to get and maintain an erection, typically concerning men over the age of 40 due to both, psychological and physical causes such as anxiety, depression, diabetes, and obesity. According to UK Conformity Assessed (UKCA), the approval of the medication is based on evidence from 2 Phase three clinical studies, which showed that 60 per cent of patients taking Eroxon achieved Minimal Clinically Important Differences (MCID) at 12 weeks.

The healthcare landscape has dramatically changed over the years, due to a number of factors, firstly having to navigate Covid-19 and now the advancement of artificial intelligence (AI) and machine technology, to name a few. As a result, training the next generation of healthcare leaders is more important now than ever. Let's look at three ways to effectively train the next generation of pharmacists: Robust Induction Programme Induction programs are an effective way of training the next generation of pharmacists as they have the ability to provide knowledge, skills and practical experience to deal with and manage common challenges they're likely to experience in their careers. These programs usually include training in pharmacokinetics, drug dosages, medication administration, and pharmacotherapy.

The heart is an extraordinary system, yet it is highly susceptible to damage due to lifestyle choices such as smoking, an unhealthy diet, or exposure to stress. The advanced infrastructure, coupled with top heart surgeons in India, is supported by specially trained staff, ensuring world-class service.

Derriford Hospital is set to move its outpatient pharmacy to a bigger unit, which will be twice as big as the current size. The new pharmacy, due to open in Spring 2024, is located adjacent to the hospital's on-site Costa Coffee shop in the multistorey car park building. University Hospitals Plymouth NHS Trust said work is ongoing on the new 155 square metres pharmacy, but measures such as covered seating has been implemented. Additionally, the pharmacy's opening times would be extended during the weekends to benefit patients who are unable to attend during the week, the Trust said, noting that demand for its services has grown by 25 per cent. Kandarp Thakkar, Chief Pharmacist & Clinical Director of Medicines Optimisation, said the pharmacy serves thousands of outpatient appointments each week.

QuickBooks credit card fees without further information. To create a valuable and relevant response, I need context on what aspect you'd like me to focus on. Any additional information you can provide will help me tailor the response to your specific needs.By utilizing these resources and tailoring your research to your specific situation, you can gain a comprehensive understanding of your QuickBooks credit card processing fees and make informed financial decisions for your business. QuickBooks Online: Standard Fees: Invoicing & Quick Requests: 2.99% per transaction for major cards like Visa, Mastercard, Discover, and American Express. Card Reader (swiped): 2.5%, the most cost-effective method due to lower interchange fees. Keyed-in Payments: 3.5%, use cautiously due to higher fees and security concerns. Digital Wallets: Same rate as invoices for Apple Pay and Google Pay. Factors Affecting Your Rates: Processing Volume: Higher transaction volumes often unlock tiered pricing with reduced fees. Explore these options if your business scales. Card Network: Visa, Mastercard, etc., have varying interchange fees impacting your overall rate (not directly controlled by QuickBooks). Additional Services: Opting for features like Instant Deposits or Dispute Protection adds to your charges. Weigh the benefits against the cost.

Nigerian patients often choose India for stem cell treatment due to its renowned medical expertise, advanced technology, and cost-effective healthcare options.

In the next 10 years, the incidence of first-time stroke cases in the UK is projected to increase by 60 per cent, costing the government £75bn in healthcare and lost productivity, a charity has suggested. A new manifesto published by the Stroke Association has urged the next UK government to make stroke "the priority", stressing that the next decade is crucial for stroke prevention, treatment and recovery. Currently, stroke is the UK's fourth biggest killer and a leading cause of disability. On a daily basis, 281 individuals experience a stroke. Next year, the cost of stroke in the UK will be £43 billion. The charity predicted that by 2035, there will be 151,000 hospital admissions due to stroke every year, averaging 414 admissions per day, with 42,000 people estimated to die every year. In 2035, the UK is projected to have 2.1 million stroke survivors, imposing a financial burden of £75 billion on the public purse, nearly half the current NHS budget.

In 2023, almost 14,000 people in England are estimated to have died due to excessive waits in emergency departments, averaging more than 260 deaths per week, according to new figures from the Royal College of Emergency Medicine (RCEM). The RCEM estimate is based on a large study of NHS patients published in the Emergency Medicine Journal in 2021, which found one excess death for every 72 patients who spent eight to 12 hours in an A&E department. Following a Freedom of Information audit of NHS trusts, the college has found that 65 per cent of people waiting 12 hours or more in A&E were patients waiting for a hospital bed. NHS data for England revealed that over 1.5 million patients waited 12 hours or more in major emergency departments last year. Based on the RCEM calculation, this indicates that over a million of those patients were waiting for a bed.

Campaigners have submitted an open letter to the Department of Health and Social Care (DHSC), urging the Minister for Primary Care and Public Health to freeze prescription charges to keep people with long-term conditions alive and well. The campaign is led by the Prescription Charges Coalition, which represents over 50 organisations, including Royal Pharmaceutical Society (RPS) and Pharmacists' Defence Association (PDA). Currently, the prescription charge is £9.65 per item, and campaigners have asked the government to freeze it for 2024 and 2025 as people living with long-term health conditions in England are "being forced to choose between heating, eating, and taking their vital medication on a daily basis." In 2023, a study conducted by the Prescription Charges Coalition revealed that almost 10 per cent of survey participants had skipped medication in the previous year due to the cost of prescriptions. This led to increased physical and mental health problems, as well as impacted the time they took off work. Laura Cockram, Chair of the Prescription Charges Coalition and Head of Campaigns at Parkinson's UK, expressed deep concern that a further rise in the charge this year will lead to people skipping or not taking the full dose of their medication, which will affect their health and put more pressure on the already under pressure NHS.

People in the UK are increasingly relying on community pharmacies for health advice and support as they are unable to access their general practitioner (GP). According to a recent report by the Liberal Democrats, there was a significant increase in the number of patients waiting four weeks or more to see a GP in England last year, rising from 12.8 million in 2022 to 17.6 million. Responding to this research report, the Royal College of General Practitioners (RCGP) highlighted that GPs are also struggling to meet the increasing demand for their services due to severe staff shortages. Dr. Victoria Tzortziou-Brown, Vice Chair of the RCGP, stated that the average number of patients each GP is responsible for has increased by 158 compared to five years ago. Although she acknowledged that many patients are forced to wait for weeks to see their GP, she said that doctors too are grappling with "unmanageable and unsustainable workloads" and "we can't keep doing more with less."

Britain's drug regulator, the Medicines and Healthcare products Regulatory Agency (MHRA) on Monday announced that fluoroquinolone antibiotics must only be administered when no other antibiotics are appropriate for use. It elaborated that fluoroquinolones given systemically (by mouth, injection, or inhalation) should only be prescribed "when other recommended antibiotics have failed, will not work due to resistance, or are unsafe to use in an individual patient." Previous regulations on fluoroquinolones stated that this class of antibiotics should not be prescribed for mild to moderate or self-limiting infections, or non-bacterial conditions. Further restrictions have been introduced after receiving reports from patients who have experienced long-lasting or disabling reactions following use of fluoroquinolones, the MHRA revealed. Dr Alison Cave, MHRA Chief Safety Officer, said: "Patient safety is our top priority. We have listened to the experience of patients regarding long-lasting and potentially irreversible adverse reactions following use of fluoroquinolone antibiotics, in some cases prescribed for mild-to-moderate infections.

NHS England is encouraging people to get their flu and Covid vaccines as hospitals dealt with the highest number of norovirus and flu cases this winter. An average of 688 patients with norovirus were in hospital each day last week, 75 per cent higher than the same time last year (393), according to the latest data from NHS England. The data also showed an average of 2,226 patients with flu in hospital each day last week, which is three-quarters higher than the same week last January (1,290). Compared to last month, there has been an 80 per cent increase in the daily count of norovirus cases and 70 per cent in flu cases. In the week ending Dec 31, NHSE recorded 1,312 hospital admissions due to norovirus and 376 and 1,312 flu cases each day.

QuickBooks Install Diagnostic tool was invented by Intuit to troubleshoot the errors that come while we install the QuickBooks Desktop. It can fix the errors that may appear due to MSXML, and C++. It identifies and troubleshoots installation errors automatically. Downloading and installing this tool can help to fix the errors.

QuickBooks Install Diagnostic Tool can be your knight in shining armor. This handy tool, readily available within the QuickBooks Tool Hub, is designed to identify and fix common installation issues, saving you time and frustration. Let's delve into its functionalities and how it can help you achieve a smooth QuickBooks installation. An About QuickBooks Install Diagnostic tool was invented by Intuit to troubleshoot the errors that come while we install the QuickBooks Desktop. It can fix the errors that may appear due to MSXML, and C++. It identifies and troubleshoots installation errors automatically. Downloading and installing this tool can help to fix the errors. Benefits of Using the Tool: By utilizing the Diagnostic Tool, you can: Save Time: Instead of manually troubleshooting, the tool automates the process, pinpointing issues swiftly. Increase Accuracy: It eliminates the guesswork, ensuring targeted solutions instead of random attempts. Boost Success Rate: By addressing core installation roadblocks, the tool significantly increases the chance of a successful installation. Simplify the Process: Even if you're not tech-savvy, the tool's user-friendly interface makes it easy to understand and use.

A new study has underscored the significance of offering customers a variety of payment choices, particularly as digital platforms gain popularity among younger age groups. Almost one in three (30 per cent) people surveyed by payments solutions provider, Access PaySuite reported a negative experience when purchasing health and wellbeing products or services due to limited payment options. The research showed that online and in-person cash payments were the most preferred modes of payment, while more than a quarter of consumers expressed their preference for paying through Direct Debit. About 17 per cent of the participants favoured using a mobile app for payments during the booking process, followed by mobile in-person options like Google Pay (14 per cent) and phone-based transactions using debit or credit card) (13 per cent).

A recent study presented at the European Congress on Obesity in Venice sheds light on the detrimental effects of obesity on workplace absenteeism and economic productivity. The analysis, encompassing data from millions of workers across Europe, reveals a direct correlation between body mass index (BMI) and the likelihood of taking sick leave. According to the study, obese individuals are up to twice as likely to take time off work due to health issues compared to those of a healthy weight. The increased sick notes among obese individuals is attributed to various complications associated with obesity, including joint pain, diabetes, depression, and heart disease. In the United Kingdom, where obesity rates are among the highest in Europe, the impact of obesity on workplace absenteeism is particularly pronounced.

A Lake District pharmacy is grappling with significant medication supply issues, affecting its ability to provide essential drugs to customers amidst nationwide drug shortages. According to Simon Butterworth, whose family has operated Collins & Butterworth Pharmacy in Hawkshead for nearly 40 years, voiced his concerns to the ITV stating that the staff is "having to spend time hunting for (medications), looking for it or doing our best to find ways to solve that problem" for distressed patients. "They've got to know when they can get the medications they need," he added. Butterworth also highlighted the financial strain pharmacies face due to the NHS's fixed tariff system. "Certain items are actually costing more to buy than we get paid for them by the NHS. An item we were trying to get this morning was 250 per cent higher than the tariff price, which is significant and builds up over lots of items," he explained.

"Record long NHS waits are forcing huge numbers of people out of work, including doctors and nurses," said Wes Streeting MP, Labour's Shadow Health and Social Care Secretary as Labour announced a new partnership with Nuffield Health today to tackle joint pain issues among NHS staff and reducing waiting lists. Musculoskeletal problems, including back, knee, hip, and neck pain, are the second leading cause of NHS staff absences, surpassed only by mental health issues. In December 2023 alone, NHS workers missed a record 198,000 days due to these issues, marking a 13 per cent increase from the 174,000 days recorded in December 2019. Nurses and health visitors accounted for 52,000 of these days, up from 47,000 pre-pandemic, while doctors took 3,500 days off, a 9 per cent increase from 2019. The partnership with Nuffield Health will provide up to 4,000 extra places for NHS staff in Nuffield Health's Joint Pain Programme at no cost.

The Company Chemists' Association (CCA) has raised concern that pharmacies may face challenges in providing placements to pharmacy students graduating in 2025 due to shortages of designated prescribing practitioners (DPPs). From the academic year 2025/26, all pharmacy students will be required to complete 90 hours of training with designated prescribing practitioners prior to their registration. However, the CCA has raised doubts regarding the availability of these healthcare professionals to provide such training. The association said: "We are concerned that pharmacies will be unable to secure DPPs. This will result in a significant reduction in the number of Foundation Pharmacist placements available within the community pharmacy sector. Consequently, a significant number of graduates leaving university next year will, unfortunately, struggle to find employment in their chosen career." As per the CCA, they have repeatedly raised their concerns with NHS England and cautioned them about the potential consequences arising from the lack of DPPs.

"If the Government does not support community pharmacies with the relevant funding, then we will see a massive number of closures," warns Dr. Leyla Hannbeck, chief executive of the Independent Pharmacies Association (IPA). The Fight4Pharmacies campaign, led by the IPA, is urging prime minister Rishi Sunak to address a critical £1.2 billion funding shortfall that threatens the survival of independent pharmacies across the UK. This urgent plea comes as 1,000 community pharmacies have closed since 2019 due to rising operational costs and insufficient reimbursements. On May 21, supporters of the Fight4Pharmacies campaign, along with 50 MPs including prominent figures like Priti Patel and Gavin Williamson, delivered a petition to Downing Street. The petition, Prescription to Save Our Pharmacies outlines how independent community pharmacies can be supported to ensure smooth running of pharmacies.

The National Pharmacy Association (NPA) views the COVID vaccination programme as broadly successful, largely due to the efforts of healthcare workers and volunteers. However, it cited some areas that could be improved, notably the early involvement of community pharmacies in planning, operational challenges, and recognising the role of community pharmacy in addressing vaccine hesitancy and inequalities. Submitting its evidence to the Covid-19 Inquiry, the NPA highlighted that the community pharmacy should have been consulted and involved earlier in the planning process, considering their two years of experience and expertise in administering annual influenza vaccination programs and the reach and resources of the 14,000 community pharmacies across the UK. "Instead, community pharmacy was initially given a gap in service role, which failed to fully utilize their experience, expertise and resource," Lawyer Brian Stanton told the Inquiry on behalf of the NPA during the Module 4 Preliminary Hearing on 22 May.